SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-20-138022
Filing Date
2020-12-21
Accepted
2020-12-21 15:35:42
Documents
1
Period of Report
2020-12-17

Document Format Files

Seq Description Document Type Size
1 4/A a4a.html 4/A  
1 4/A a4a.xml 4/A 5184
  Complete submission text file 0001104659-20-138022.txt   6562
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Issuer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38459 | Film No.: 201404188